On March 19, 2024, Elicio Therapeutics, Inc closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.85 USD | -0.11% | -11.94% | +6.12% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.12% | 8.6Cr | |
+67.53% | 6.39TCr | |
-0.77% | 4.18TCr | |
+45.66% | 4.07TCr | |
-10.72% | 2.71TCr | |
+13.30% | 2.65TCr | |
-22.79% | 1.87TCr | |
+4.70% | 1.27TCr | |
+24.10% | 1.21TCr | |
+27.41% | 1.21TCr |
- Stock Market
- Equities
- ELTX Stock
- News Elicio Therapeutics, Inc.
- Elicio Therapeutics, Inc. announced that it has received $5.999999 million in funding from Gkcc, LLC